Industry, Consumer Groups Seek Re-Think Of FDA’s GRAS Process

March 21, 2019
Stakeholders representing both industry and consumers called for a re-think of FDA’s generally-recognized-as-safe (GRAS) process, where companies can put a new ingredient in food without agency review. The policy's lack of transparency erodes consumer trust in the ingredients in their food, the stakeholders said. Laura MacCleery, policy director for the Center for Science in the Public Interest, and Alison Bodor, president and CEO of the American Frozen Food Institute, both advocated for a transparent, risk- and science-based approach for reviewing...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.